company:myriad genetics

Congress Is Debating—Again—Whether Genes Can Be Patented
▻https://www.wired.com/story/congress-is-debating-again-whether-genes-can-be-patented

In 2013, the Supreme Court unanimously struck down patents on two human genes—BRCA1 and BRCA2—associated with breast and ovarian cancers. Justice Clarence Thomas wrote for the court at the time that isolated DNA “is a product of nature and not patent eligible.” The historic decision invalidated patents held by Myriad Genetics, the defendant in a 2009 lawsuit brought by dozens of patients and researchers represented by the American Civil Liberties Union, breaking the company’s virtual monopoly (...)

#Google #Amazon #Facebook #génétique #législation #brevet #ACLU

https://media.wired.com/photos/5cf708ef8f6eb22767598ef9/191:100/pass/Science%20-%20Feature%20art%20-%20Genome%20patent%20law%20-%20165809667.jpg

Genetic profiteering : scandal of firm ’hiding vital breast cancer data’ - Science - News - The Independent
►http://www.independent.co.uk/news/science/genetic-profiteering-scandal-of-firm-hiding-vital-breast-cancer-data-

Myriad Genetics is accused of deliberately withholding data that could help other scientists to understand cancer genetics, on the grounds that the information is commercially sensitive.

#génétique #brevets #secret_commercial #santé #cancer

US court sides with gene patents | Nature
►http://blogs.nature.com/news/2012/08/us-court-sides-with-gene-patents.html

The lawsuit against Myriad Genetics, a diagnostic company, based in Salt Lake City, Utah, that holds patents on the genes BRCA1 and BRCA2, has bounced from court to court since 2010. In a 2-1 decision today, a federal appeals court reaffirmed their latest decision that genes represent patent-eligible matter.

#brevets #médecine #biologie #santé